Explore more Articles in
Capital Markets
How AI is Transforming SEO in India: The Rise of Intelligent Digital Marketing
Mumbai, Maharashtra, India | 8th November 2025: India’s digital marketing and SEO landscape is undergoing a groundbreaking transformation. The era of keyword stuffing, directory...
Auxilium Opportunity Foundation (Under 750AD Group) Announces Free Mega Health Camp in New Delhi on November 9
Residents of Delhi can access free medical services and discounted medicines at the health camp organized by Auxilium Foundation.
Fueling India’s Green Revolution: How Buyofuel is Disrupting the Bioenergy Market
Discover how Buyofuel is transforming India’s fragmented bioenergy sector into a trusted, tech-enabled ecosystem with ₹10 Cr in monthly revenue.
Vite+ Debuts with $12.5M in Series A Funding to Simplify JavaScript Workflows
With 36M weekly downloads, Vite+ is poised to become the default toolkit for JavaScript developers globally.
IPOs
Weekly IPO Watch: September Kicks Off with Healthcare, Construction & SME Expansion
September 2025 IPO update: Diverse SME listings and a major healthcare IPO mark a strong start to the month. Full breakdown inside.
IPOs
Weekly IPO Watch: Late August 2025 Brings Diverse Investment Opportunities Across Mainboard & SME Markets
Explore 7 diverse IPO opportunities in late August 2025. From ₹14K mainboard options to ₹1.45L SME investments across infrastructure, healthcare & tech sectors.
IPOs
Weekly IPO Watch: Studio LSD, Patel Retail, LGT Business Connextions Lead Diverse Market Offerings
Explore 6 diverse IPO opportunities this week including Studio LSD entertainment, Vikram Solar energy, and retail investments starting from ₹13,746.
Capital Chronicles
Bluspring Reports ₹2,969 Cr Revenue in FY25 in First Financial Results as Independent Listed Entity
With positive adjusted PAT and cash reserves, Bluspring sets the stage for scalable growth in FY26.
Capital Markets
Business Growth Champion Suresh Mansharamani to Host ‘SME to IPO’ Workshop in Mumbai on June 21, 2025
Learn real-world frameworks for valuation, team building, and capital strategy from India’s most respected growth mentor.
Capital Chronicles
Akums Reports Strong Q4 and FY25 Financial Performance, Expands Global CDMO Footprint
Akums strengthens its pharmaceutical CDMO leadership with robust financials, reporting ₹1,073 crore in Q4 FY25 revenue.
- Our Sponsors -
Explore the dynamic world of Capital Markets on Startup Success Stories. Dive into inspiring narratives of IPO triumphs, venture capital successes, angel-backed innovations, and disruptive fintech breakthroughs.